CME GroupCME +2.05%90 EBIT per Share is $15.99 as of Mar. 2026. GuruFocus rates CME with a GF Score™ of 90/100 and a GF Value™ of $270.96 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 489 Capital Markets companies, CME Group ranks worse than 50.1% on this metric.
CME Group's EBIT per Share for the
three
months ended in Mar. 2026 was $4.28.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $15.99.
During the past 12 months, the average EBIT per Share Growth Rate of CME Group was 8.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 11.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 11.00% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 6.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for CME Group's EBIT per Share or its related term are showing as below:
CME'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -4.6 Med: 8.85 Max: 42.8
Current: 11.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of CME Group was 42.80% per year. The lowest was -4.60% per year. And the median was 8.85% per year.
CME's 3-Year EBIT Growth Rate is ranked worse than 50.1% of 489
companies
in the Capital Markets industry
Industry Median: 11.8
vs CME: 11.80
CME Group's EBIT for the
three
months ended in Mar. 2026 was $1,555 Mil.
CME Group (NAS:CME) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
CME Group EBIT per Share Related Terms
CME Group EBIT per Share Historical Data
* Premium members only.
The historical data trend for CME Group's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME Group (CME) has a EBIT per Share of $15.99 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on CME Group and its competitors. According to the industry distribution chart, CME Group ranks #245 out of 489 companies in the Capital Markets industry, placing it in the top 50.1%.
Is CME Group's EBIT per Share too high?
CME Group's current EBIT per Share is $15.99. The Capital Markets industry median EBIT per Share is 11.80. CME Group's value of $15.99 is 35.5% above this industry median. Based on the distribution chart, CME Group ranks #245 out of 489 companies in the Capital Markets industry, which is below the industry midpoint. Overall, CME Group has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's EBIT per Share compare to MCO and ICE?
According to the Capital Markets industry distribution chart, CME Group ranks #245 out of 489 companies for EBIT per Share. This places CME Group in the lower half of its industry. The industry median EBIT per Share is 11.80. CME Group's value of $15.99 is 35.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Capital Markets company?
The median EBIT per Share among Capital Markets companies is 11.80, based on 489 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current EBIT per Share of $15.99 is 35.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on CME Group and its competitors. For the Capital Markets industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current EBIT per Share is $15.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $270.96, compared to a current price of $223.06 — trading 17.7% below its estimated fair value. The current EBIT per Share is $15.99 and 35.5% above the Capital Markets industry median of 11.80. CME Group's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For CME Group (CME), the current EBIT per Share is $15.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $223.06 is trading 17.7% below its estimated GF Value™ of $270.96.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for CME:
EBIT per Share: $15.99
GF Value™: $270.96 vs. price of $223.06 (17.7% below fair value)
Industry Position: 35.5% above the Capital Markets median (#245 of 489)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
90GF Score
Get the complete analysis for CME
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 
